| Gene Set | Leading Edge Genes |
|---|
| DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | GMPR2, ABCE1, MAGOH, CETN2, DAD1, PRDX4, CETN3, ALG5, TCF12, MRPL3, RAD50, POLR2B, MRPS30, GOT2, EI24, ADH5, NDUFA8, CHERP, BTBD1, RPA2, POLD2, ACTL6A, ECHS1, ANAPC1, TERF1, KIF22, HS2ST1, PPP2R1B, CNIH, DAPK1, RALBP1, IDH3B, CHD1L, KLHDC2, CD2AP, NFATC3, ABCB6, NT5C, CCT6A, PHKB, AMD1, WHSC2, LMAN1, SHMT1, ADCY7, SEPHS2, SMC3, NUDT21, CUL4B, API5, PXMP3, DDB1, SC4MOL, GMNN, GSS, GCLC, PECI, MKRN1, ALDH6A1, PRKRA, NDUFB6, DCTN6, PRDX3, IKBKAP, GMFB, SMC4, USP1, HSD17B4, MDH2, PRPSAP2, ZMYND11, RAD1, TM9SF1, TCERG1, NDUFA5, C1QBP, DBF4, GART, STOML2, NCBP2, SS18, GALNT2, UCHL5, GALC, ORC5L, TOPBP1, SIP1, FNTA, RREB1, LANCL1, CBFB, CDC23, MTX2, PPA2, SSBP1, CAPN7, NDUFAB1, PGRMC2, ZNF22, LSM5, BAG4, SOD1, DDX10, ORC2L, BCAP29, CMAS, ACO1, ACADM, YEATS4, MSH6, TSNAX, RNASEH1, FADS1, DHX9, ZMPSTE24, ANP32A, GMPR, CDK8, HDAC2, KIFAP3, ACLY, ATXN10, AUP1 |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | FKBP5, MRPL9, MAGOH, CETN2, DAD1, NUDCD2, IARS2, RIOK2, BRP44, NDUFA8, BOLA1, ACTL6A, PDCD2L, TERF2, CNIH, NANS, TSPAN14, NUDT2, NOL7, RPP21, GOLT1B, NUCB2, GNPAT, MRPL40, SMC3, TMEM147, MRPL36, DNMT1, MRPL18, GMNN, NUP37, DNAJC9, NDUFB6, WDR61, GMFB, MRPL48, RSRC1, C1QBP, NUPL2, PRPSAP1, ANKMY2, NCBP2, NUP133, NDUFB5, LARS, UCHL5, THAP11, PDIA6, MRPS23, ACP1, CHCHD1, TOR1B, POLR2H, CKS2, REXO2, PDCD7, STT3B, ZFAND1, ASPM, LRRC42, HPRT1, SLC35B1, RBBP7, RPA3, CCNA2, MSH6, DNAJC19, TSNAX, ANKRD49, ZMPSTE24, KIFAP3, ACLY, KDELR2, TMEM14C |
| CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN | ATF1, ACTR6, C1QBP, DAD1, EBPL, PRDX4, CDK4, STOML2, CMAS, SYPL1, RPA3, ADH5, NUDT21, ECT2, GMNN, PDIA6, MSH2, MRPS23, ME2, NUP37, CENPH, NDUFA4, XRCC5, WDR61, SLC39A6 |
| BOYAULT LIVER CANCER SUBCLASS G3 UP | CASC3, TPRKB, NARS, NUP155, ADSL, CCNA2, TOPBP1, ANP32E, SNRPA1, KPNB1, ACTL6A, LANCL1, DUSP3, NUP37, TSN, TIPIN, GMFB |
| REACTOME METABOLISM OF RNA | SNRPE, EXOSC1, EXOSC8, NUPL2, NUP37, DCPS, NUP54, NUP93, NUP155, SNRPD3, NCBP2, NUP133, LSM5, SIP1 |
| BENPORATH MYC MAX TARGETS | |
| REACTOME MRNA 3 END PROCESSING | |
| REACTOME LATE PHASE OF HIV LIFE CYCLE | POLR2F, NUP37, POLR2I, CCNH, TAF10, NUP155, POLR2H, WHSC2, POLR2B, SSRP1, NCBP2, NUP133, MNAT1 |
| REACTOME CELL CYCLE CHECKPOINTS | |
| REACTOME RNA POLYMERASE I PROMOTER CLEARANCE | |
| REACTOME RNA POLYMERASE II TRANSCRIPTION | MAGOH, POLR2F, CPSF3, POLR2I, TAF10, POLR2H, WHSC2, POLR2B, SSRP1, NCBP2, CSTF1, NUDT21, MNAT1 |
| NCI PHOSPHORYLATION OF THE APC C | |
| REACTOME CENTROSOME MATURATION | |
| BOGNI TREATMENT RELATED MYELOID LEUKEMIA DN | |
| REACTOME RNA POLYMERASE I III AND MITOCHONDRIAL TRANSCRIPTION | NFIC, RRN3, SNAPC5, POLR2F |
| LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | |
| YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 10 | |
| REACTOME MICRORNA BIOGENESIS | POLR2B, POLR2F |
| NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A | |
| GARY CD5 TARGETS DN | |
| LINDGREN BLADDER CANCER WITH LOH IN CHR9Q | |
| ZHANG RESPONSE TO IKK INHIBITOR AND TNF DN | |
| KEGG SPLICEOSOME | |
| STARK PREFRONTAL CORTEX 22Q11 DELETION DN | |
| ZHONG RESPONSE TO AZACITIDINE AND TSA DN | |
| REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX | |
| NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX | |
| MOREAUX MULTIPLE MYELOMA BY TACI DN | |
| REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B | |
| REACTOME TRANSCRIPTION | RRN3, MAGOH, POLR2F, CPSF3, POLR2I, TAF10, WHSC2, POLR2B, SSRP1, NFIC, NCBP2, TFAM, CSTF1 |
| REACTOME HIV INFECTION | |
| REACTOME HIV LIFE CYCLE | POLR2F, NUP37, POLR2I, CCNH, TAF10, NUP155, POLR2H, WHSC2, POLR2B, SSRP1, NCBP2, NUP133, MNAT1 |
| NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | |
| REACTOME PHOSPHORYLATION OF THE APC | |